中/EN: 中文繁體 English

Investor Relations
IR Home Corporate Overview Financial Highlights Financial Reports ESG Reports Regulatory Filings Press Releases Company Presentations Stock Quotes & Charts Analyst Coverage FAQs IR Contact
Corporate

Press Releases

2019

Please select

AUG
25

The United Laboratories International Holdings Limited Announces 2019 Interim Results, Profit Attributable to Shareholders up 224.6% Good Performance in the Sales of Insulin Glargine

MAR
29

The United Laboratories International Holdings Limited Recorded a Significant Growth in Profit for FY2018, Profit Attributable to Shareholders Increased by 735.3% to RMB682.9 Million, Good Progress in New Product Research and Development